These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26260612)

  • 1. Platelet Reactivity: Is There a Role to Switch?
    Aradi D; Merkely B; Komócsi A
    Prog Cardiovasc Dis; 2015; 58(3):278-84. PubMed ID: 26260612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?
    Garratt KN
    Prog Cardiovasc Dis; 2015; 58(3):285-98. PubMed ID: 26343876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.
    Mayer K; Schulz S; Bernlochner I; Morath T; Braun S; Hausleiter J; Massberg S; Schunkert H; Laugwitz KL; Kastrati A; Sibbing D
    Thromb Haemost; 2014 Aug; 112(2):342-51. PubMed ID: 24718389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
    Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
    JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting.
    Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM
    Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Antiplatelet Agents: The Current State and What Is Coming Down the Pike.
    Franchi F; Rollini F; Park Y; Angiolillo DJ
    Prog Cardiovasc Dis; 2015; 58(3):267-77. PubMed ID: 26277706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
    Naspro R; Rossini R; Musumeci G; Gadda F; Pozzo LF
    Eur Urol; 2013 Jul; 64(1):101-5. PubMed ID: 23428067
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet function testing and tailored antiplatelet therapy.
    Janssen PW; ten Berg JM
    J Cardiovasc Transl Res; 2013 Jun; 6(3):316-28. PubMed ID: 23543615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point of care platelet activity measurement in primary PCI [PINPOINT-PPCI]: a protocol paper.
    Johnson TW; Marsden D; Mumford A; Pike K; Mundell S; Butler M; Strange JW; Bowles R; Rogers C; Baumbach A; Reeves BC
    BMC Cardiovasc Disord; 2014 Apr; 14():44. PubMed ID: 24708700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized antiplatelet therapy: the wrong approach?
    Collet JP; Montalescot G
    Arch Cardiovasc Dis; 2013 Oct; 106(10):481-6. PubMed ID: 24080323
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet therapy management in patients with coronary stent undergoing vascular surgery.
    Bozzani A; Ferlini M; Rossini R; Musumeci G; Arici V; Bramucci E; Setacci C
    J Cardiovasc Surg (Torino); 2015 Aug; 56(4):681-3. PubMed ID: 25008060
    [No Abstract]   [Full Text] [Related]  

  • 16. Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Alexopoulos D; Xenogiannis I; Vlachakis P; Tantry U; Gurbel PA
    Thromb Haemost; 2018 Jul; 118(7):1131-1140. PubMed ID: 29864784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G; Pasceri V; Vizzi V; Ricottini E; Di Sciascio G
    Am J Cardiol; 2011 Apr; 107(7):995-1000. PubMed ID: 21256470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet Function Testing in Patients on Antiplatelet Medications.
    Gross L; Aradi D; Sibbing D
    Semin Thromb Hemost; 2016 Apr; 42(3):306-20. PubMed ID: 26886395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.
    Orban M; Mayer K; Morath T; Bernlochner I; Hadamitzky M; Braun S; Schulz S; Hoppmann P; Hausleiter J; Tiroch K; Mehilli J; Schunkert H; Massberg S; Laugwitz KL; Sibbing D; Kastrati A
    Thromb Haemost; 2014 Dec; 112(6):1190-7. PubMed ID: 25183544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.